Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zentalis Pharmaceuticals, Inc. | Chief Scientific Officer | Common Stock | 196K | $2.26M | $11.54 | Feb 2, 2024 | Direct |
Zentalis Pharmaceuticals, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 141K | Feb 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZNTL | Zentalis Pharmaceuticals, Inc. | Feb 1, 2024 | 3 | -$18.3K | 4 | Feb 5, 2024 | Chief Scientific Officer |
ZNTL | Zentalis Pharmaceuticals, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 3, 2024 | Chief Scientific Officer |
ZNTL | Zentalis Pharmaceuticals, Inc. | Dec 31, 2023 | 0 | $0 | 3 | Jan 3, 2024 | Chief Scientific Officer |